United Therapeutics (UTHR) Posts Q3 adj.-EPS of $2.98; Raises FY13 Revs Outlook

October 29, 2013 6:28 AM

United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $2.98, $1.39 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found